Entresto in children with chronic heart failure
Part of Heart & circulation clinical trials.
This study is for children with chronic heart failure who are starting Entresto for the first time. It helps doctors learn how well the medicine works and how safe it is for kids.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child must be between 1 and 17 years old.
- You must be starting Entresto for the first time to treat chronic heart failure.
- A parent or guardian must sign a consent form before you start the medicine.
- You cannot have taken any medicine with the same ingredient as Entresto before.
- You must not have a history of allergic reaction to Entresto or its ingredients.
- You cannot be taking an ACE inhibitor (a type of blood pressure medicine) or have stopped one within the last 36 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a drug called sacubitril-valsartan can improve heart structure and function in adults with congenital heart disease. You will take the drug and have heart imaging to see changes.
This study tests a medicine called finerenone in children with heart failure. It looks at whether finerenone helps the heart work better and is safe compared to a placebo (a dummy pill), when taken with the usual heart-failure medicines.
This study compares two types of heart failure medicines, ARNI and ACE inhibitors, to see which works better for children with dilated cardiomyopathy (a weakened heart muscle that affects pumping). It may help improve heart function and quality of life in children.
This study tests an investigational medicine called EDG-15400 for people with a type of heart failure where the heart muscle is stiff and doesn't relax properly, even though the pumping function is normal. The goal is to see if the medicine improves symptoms and daily functioning.
This trial tests if empagliflozin, a diabetes medicine that also helps the heart, can improve symptoms in children with heart failure. It may help kids with severe symptoms or high levels of a heart stress marker called BNP.
This trial tests a medicine injected into the body that may help children with heart failure. It aims to see if it can improve how well the heart pumps blood, and it is done in a hospital setting.
Hear when a new Pediatric Chronic Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.